LATE BREAKING CLINICAL TRIAL: Cost-Effectiveness of Transcatheter Aortic Valve Replacement for Low-Risk Patients Updated Results from the Evolut Low Risk Trial

Published: May 21, 2024, 9 a.m.

LATE BREAKING CLINICAL TRIAL: Cost-Effectiveness of Transcatheter Aortic Valve Replacement for Low-Risk Patients \u2013 Updated Results from the Evolut Low Risk Trial